About CNATM - Cluster for Nucleic Acid Therapeutics Munich
The Cluster for Nucleic Acid Therapeutics (CNATM) is one of the winners of the Cluster4Future competition organised by the German Federal Ministry of Education and Research (BMBF). CNATM brings together scientists from the leading universities of LMU and TUM, the Universities of Regensburg and Würzburg, the Helmholtz Zentrum München and 17 companies from the Munich region to research nucleic acid therapeutics for the pharmaceutical market of the future. The focus is on the translation of academic basic research into the pharmaceutical industry.
- Employees
- 1 to 10
- Headquarters
- Germany
Leadership
The top of CNATM - Cluster for Nucleic Acid Therapeutics Munich's org chart, with how many people report into each leader.
Dr. Nada Raddaoui
Managing director
Jobs at CNATM - Cluster for Nucleic Acid Therapeutics Munich
No open positions right now. Explore more companies on TheJobsMap.